Trademark: MYELOVAX
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for MYELOVAX
We do not have any records of a proof of use for MYELOVAX at this moment.
Possible trademark infringements of MYELOVAX
Basic Information about MYELOVAX
- Serial Number
- 97722425
- Filing Date
- 19 Dec 2022
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of MYELOVAX on the blockchain with WikiTrademarks.io.
- First use of MYELOVAX anywhere
- MYELOVAX was first used on 20 May 2005 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 005; 006; 018; 044; 046; 051; 052
Who owns MYELOVAX?
1. Meridian Therapeutics Inc. Lehi, UT
2. Meridian Therapeutics Inc. Lehi, UT
Correspondent
- Mark David Torche Patwrite Law
- 408 W Main St,
- Marshalltown, IA 50158
- United States
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io